Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis

Contributed by: Business Wire

Logo

Tags

Health

Infectious Diseases

Other Science

Research

Science

Pharmaceutical

Biotechnology

Fluxus

More Like This

Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

BioGX Candida Auris PCR Assay Global Adoption Accelerates

Tuberculosis levels in England increased by 11% in 2023

CGTN: China advances battle against tuberculosis

Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu

LifeArc - New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance

Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease